EP
Eversept Partners’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.1M | Sell |
4,065,355
-146,915
| -3% | -$1.38M | 3.5% | 7 |
|
|
2025
Q1 | $51.7M | Buy |
4,212,270
+3,868,870
| +1,127% | +$47.5M | 5.26% | 4 |
|
|
2024
Q4 | $4.54M | Sell |
343,400
-3,761,913
| -92% | -$49.7M | 0.4% | 39 |
|
|
2024
Q3 | $79M | Buy |
4,105,313
+491,682
| +14% | +$9.46M | 5.41% | 5 |
|
|
2024
Q2 | $74.2M | Buy |
3,613,631
+480,518
| +15% | +$9.87M | 5.08% | 6 |
|
|
2024
Q1 | $74.6M | Sell |
3,133,113
-250,131
| -7% | -$5.95M | 4.97% | 6 |
|
|
2023
Q4 | $73.1M | Buy |
3,383,244
+786,999
| +30% | +$17M | 6.42% | 3 |
|
|
2023
Q3 | $37.7M | Buy |
2,596,245
+406,513
| +19% | +$5.9M | 3.19% | 6 |
|
|
2023
Q2 | $45.8M | Sell |
2,189,732
-19,325
| -0.9% | -$404K | 3.83% | 6 |
|
|
2023
Q1 | $46.7M | Buy |
2,209,057
+588,344
| +36% | +$12.4M | 3.25% | 6 |
|
|
2022
Q4 | $41.2M | Buy |
1,620,713
+409,279
| +34% | +$10.4M | 3.61% | 8 |
|
|
2022
Q3 | $29.1M | Buy |
1,211,434
+217,072
| +22% | +$5.22M | 2.52% | 9 |
|
|
2022
Q2 | $19.1M | Buy |
+994,362
| New | +$19.1M | 1.36% | 17 |
|